Tectonic Therapeutic | Frais De Vente Et D'Administration



Selling And Administration Expenses Changement Date
Adcock Ingram Holdings ZAR 997.56M 6.08M 2024-06
Alnylam Pharmaceuticals USD 295.34M 74.35M 2024-12
Celltrion KRW 239.71B 17.94B 2024-09
Cspc Pharmaceutical CNY 2.1B 22.82M 2024-09
Dianthus Therapeutics USD 6.83M 287K 2024-12
Ecofibre AUD 8.03M 1.38M 2024-06
Gilead Sciences USD 1.86B 451M 2024-12
Ionis Pharmaceuticals USD 88.08M 26.44M 2024-12
Kangmei Pharma CNY 245.26M 66.07M 2024-09
Knight Therapeutics CAD 25.48M 119K 2024-09
Laboratorios Farma EUR 32.57M 26.69M 2024-06
MacroGenics USD 27.81M 13.71M 2024-12
Malin Corporation EUR 700K 1.6M 2024-06
Medical Developments International AUD 7.07M 15.4M 2024-06
Neuren Pharmaceuticals AUD 2.33M 47K 2024-12
Organigram Holdings CAD 17.19M 2.88M 2024-12
Pfizer USD 4.27B 1.06B 2024-12
Pharma Mar EUR 13.23M 2.55M 2024-12
Qiagen NV USD 141.71M 1.05M 2024-12
Roche Holding CHF 3.61B 381M 2024-12
Sanofi EUR 2.68B 26M 2024-09
Sarepta Therapeutics USD 163.87M 35.67M 2024-12
Sartorius EUR 231.9M 13.6M 2025-03
Sino Biopharmaceutical CNY 5.31B 1.89B 2024-12
Takeda JPY 270.59B 2.31B 2024-12
Tilray USD 72.38M 4.99M 2024-11
Zz Pientze Pharmaceu 168.44M 20.66M 2024-09



Tectonic Therapeutic Frais De Vente Et D'Administration - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.